Page last updated: 2024-11-02

pantoprazole and Dermatitis, Atopic

pantoprazole has been researched along with Dermatitis, Atopic in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van der Schaft, J1
van Schaik, RH1
van den Broek, MP1
Bruijnzeel-Koomen, CA1
de Bruin-Weller, MS1

Other Studies

1 other study available for pantoprazole and Dermatitis, Atopic

ArticleYear
Increased liver enzyme levels during azathioprine treatment: beware of concomitant use of proton pump inhibitors.
    The British journal of dermatology, 2015, Volume: 173, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine Transaminase; Azathioprine; Dermatitis, Atopi

2015